GECRX Performance — GMO Emerging Markets Series Fund, Class R6
Data updated: 2021-01-29
GECRX returned +7.27% over one year to Nov 2020. Over one year the fund beat its Money Market category average: $100 grew to $107, against $105 for the category. Volatility over the past 12 months was 24.75% a year. In the 12 months to Nov 2020 the fund took in a net $7.5M, and assets reached $34.73M.
GECRX Growth of $100
What $100 invested in GMO Emerging Markets Series Fund grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Money Market category average over the same months.
| Period | GECRX | Category average |
|---|---|---|
| 1 year (Dec 2019 – Nov 2020) | $107 | $105 |
| Since data start (Sep 2019 – Nov 2020) | $115 | $109 |
GECRX Trailing Returns
Total returns to Nov 2020, from SEC N-PORT.
| Period | Total return |
|---|---|
| 1 year | +7.27% |
GECRX Annual Returns
Calendar-year total returns of GMO Emerging Markets Series Fund, compounded from monthly SEC N-PORT returns. Partial years show the months covered.
| Year | Total return |
|---|---|
| 2020 (Jan–Nov) | −0.23% |
| 2019 (Sep–Dec) | +15.15% |
GECRX Monthly Returns
Monthly total returns as reported on SEC Form N-PORT.
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2020 | −6.5% | −4.3% | −15.1% | +8.6% | +1.9% | +4.5% | +6.4% | +0.6% | −2.7% | +0.3% | +8.8% | — |
| 2019 | — | — | — | — | — | — | — | — | +3.0% | +3.7% | +0.3% | +7.5% |
GECRX Risk
Risk measures from monthly returns over Dec 2019 – Nov 2020.
- 1-year volatility (annualised): 24.75%
- Best month: +8.75% (Nov 2020)
- Worst month: −15.14% (Mar 2020)
GECRX Fund Flows
Monthly money in and out of GMO Emerging Markets Series Fund, from SEC Form N-PORT.
- 12-month net flow: $7.5M
- 12-month gross sales (incl. reinvestments): $14.6M
- Sales ÷ redemptions: 2.06×
| Month | Sales | Redemptions | Net flow |
|---|---|---|---|
| Nov 2020 | $812K | $921K | −$109K |
| Oct 2020 | $272K | $247K | $26K |
| Sep 2020 | $255K | $1.2M | −$920K |
| Aug 2020 | $138K | $801K | −$663K |
| Jul 2020 | $646K | $767K | −$121K |
| Jun 2020 | $296K | $234K | $62K |
| May 2020 | $261K | $327K | −$66K |
| Apr 2020 | $8.2M | $1.5M | $6.7M |
| Mar 2020 | $1.3M | $586K | $690K |
| Feb 2020 | $391K | $160K | $232K |
| Jan 2020 | $589K | $234K | $355K |
| Dec 2019 | $1.5M | $163K | $1.3M |
GECRX Assets Under Management
Net assets of GMO Emerging Markets Series Fund by report date, from SEC N-PORT filings.
| Report date | Net assets |
|---|---|
| 2020-11-30 | $34.73M |
| 2020-08-31 | $33.72M |
| 2020-05-31 | $30.93M |
| 2020-02-29 | $24.84M |
| 2019-11-30 | $25.02M |
For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.